Pregabaline effect on visual analog scale values after lumbar inter-laminar epidural corticosteroid injection

Volume: 53 Number: 3 September 1, 2014
  • Yektaş A
  • Gümüş F
  • Erkalp K
  • Lagöl A
EN TR

Pregabaline effect on visual analog scale values after lumbar inter-laminar epidural corticosteroid injection

Abstract

Aim: Inter-laminar lumbar epidural corticosteroid injection (ILECI) is a minimally invasive treatment method that is used in low-back pain. In this study, we aimed at investigating the effect of pregabalin administration on VAS values in patients with radiculopathy who have a disk hernia following administration of ILECI. Materials and Methods: The records pertaining to 100 patients who presented to our outpatient clinic were retrospectively examined; the patients were divided into two groups: Group P, the patients who received pregabalin and Group Z, the patients who did not receive pregabalin. The visual analogue scale (VAS) scores were assessed in week 1, months 1-6 and year 1. Results: The VAS scores of Group P and Group Z in week 1, months 1-6 and year 1 were lower than the baseline VAS scores at a statistically significant level. Based on a comparison between Group P and Group Z, it was seen that the VAS scores in months 1-6 and year 1 were lower for Group P at a statistically significant level. The post-administration patient satisfaction in Group P was higher than Group Z at a statistically significant level. Conclusion: Pregabalin significantly reduces the VAS scores in patients with radiculopathy who have received ILECI, it also decreases the frequency of ILECI administration and increases post-administration patient satisfaction.

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Yektaş A

Gümüş F

Erkalp K

Lagöl A

Publication Date

September 1, 2014

Submission Date

September 1, 2014

Acceptance Date

-

Published in Issue

Year 2014 Volume: 53 Number: 3

APA
A, Y., F, G., K, E., & A, L. (2014). Pregabalinin lomber interlaminar epidural kortikosteroid enjeksiyonu uygulaması sonrası vizüel analog skala değerlerine etkisi. Ege Tıp Dergisi, 53(3), 145-153. https://doi.org/10.19161/etd.344074
AMA
1.A Y, F G, K E, A L. Pregabalinin lomber interlaminar epidural kortikosteroid enjeksiyonu uygulaması sonrası vizüel analog skala değerlerine etkisi. EJM. 2014;53(3):145-153. doi:10.19161/etd.344074
Chicago
A, Yektaş, Gümüş F, Erkalp K, and Lagöl A. 2014. “Pregabalinin Lomber Interlaminar Epidural Kortikosteroid Enjeksiyonu Uygulaması Sonrası Vizüel Analog Skala Değerlerine Etkisi”. Ege Tıp Dergisi 53 (3): 145-53. https://doi.org/10.19161/etd.344074.
EndNote
A Y, F G, K E, A L (September 1, 2014) Pregabalinin lomber interlaminar epidural kortikosteroid enjeksiyonu uygulaması sonrası vizüel analog skala değerlerine etkisi. Ege Tıp Dergisi 53 3 145–153.
IEEE
[1]Y. A, G. F, E. K, and L. A, “Pregabalinin lomber interlaminar epidural kortikosteroid enjeksiyonu uygulaması sonrası vizüel analog skala değerlerine etkisi”, EJM, vol. 53, no. 3, pp. 145–153, Sept. 2014, doi: 10.19161/etd.344074.
ISNAD
A, Yektaş - F, Gümüş - K, Erkalp - A, Lagöl. “Pregabalinin Lomber Interlaminar Epidural Kortikosteroid Enjeksiyonu Uygulaması Sonrası Vizüel Analog Skala Değerlerine Etkisi”. Ege Tıp Dergisi 53/3 (September 1, 2014): 145-153. https://doi.org/10.19161/etd.344074.
JAMA
1.A Y, F G, K E, A L. Pregabalinin lomber interlaminar epidural kortikosteroid enjeksiyonu uygulaması sonrası vizüel analog skala değerlerine etkisi. EJM. 2014;53:145–153.
MLA
A, Yektaş, et al. “Pregabalinin Lomber Interlaminar Epidural Kortikosteroid Enjeksiyonu Uygulaması Sonrası Vizüel Analog Skala Değerlerine Etkisi”. Ege Tıp Dergisi, vol. 53, no. 3, Sept. 2014, pp. 145-53, doi:10.19161/etd.344074.
Vancouver
1.Yektaş A, Gümüş F, Erkalp K, Lagöl A. Pregabalinin lomber interlaminar epidural kortikosteroid enjeksiyonu uygulaması sonrası vizüel analog skala değerlerine etkisi. EJM. 2014 Sep. 1;53(3):145-53. doi:10.19161/etd.344074

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.